print_label | resize_label

For postmenopausal women with HR+ breast cancer

ARIMIDEX Direct shipped directly to you for $30 a month. Enroll Now.

This program is not valid for prescriptions purchased under Medicaid or similar state or federally funded medical assistance programs. Medicare Part D prescription orders will be processed without the use of insurance and cannot be applied to true out-of-pocket (TrOOP) costs. Prescription required.

ARIMIDEX Direct–Get support you can trust from the brand you know.

If you're a postmenopausal woman being treated for HR+ early breast cancer, you and your doctor may be considering ARIMIDEX, also called anastrozole, to reduce the risk of breast cancer recurrence. You can get ARIMIDEX, the #1 most-prescribed branded aromatase inhibitor, shipped directly to you for $30 per month, with ARIMIDEX Direct.

ARIMIDEX Direct offers more than just savings (compared to retail brand price). You’ll also receive free shipping, automatic refills, and refill reminders to help keep you from missing a single dose. Enroll now to receive brand-name ARIMIDEX shipped directly to you, straight from the original manufacturer, AstraZeneca.

Important Safety Information About ARIMIDEX

  • Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child. Do not take ARIMIDEX if you are allergic to any of its ingredients
  •  
  • Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen
  •  
  • ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%)
  •  
  • In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported
  •  
  • In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache
  •  
  • In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and weakness, pain, back pain, headache, bone pain, increased cough, shortness of breath, sore throat, and swelling of arms and legs. Joint pain/stiffness has been reported in association with the use of ARIMIDEX
  •  
  • ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies

Approved Uses for ARIMIDEX

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.

For more information, see your doctor.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

 This site is intended for US consumers only.

Important Safety Information About ARIMIDEX

Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child. Do not take ARIMIDEX if you are allergic to any of its ingredients.

Click here for additional safety information.

Approved Uses for ARIMIDEX

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

Click here for additional information.

ARIMIDEX® (anastrozole) Direct Web site Badge

Like this badge and show your support for the ARIMIDEX Direct Program.

Copy and paste the code below to publish the badge to your Web site or blog.

 

If you have been diagnosed with HR+ metastatic breast cancer, there are options.

Learn more about your options.